TissueGene has completed enrolling patients in a US-based Phase II trial of its TG-C therapy, designed to treat patients with Grade 3 chronic degenerative joint disease (DJD) of the knee. Comprising human allogeneic chondrocytes, the TG-C ...
Tags: TG-C therapy, therapeutic protein, TG-C
HEI, a printed circuit board fabricator, has received Zeta certification from Integral Technology, which manufactures HDI electronic materials for the PCB industry. With the certification, HEI has gained rights to produce circuit boards ...
Tags: printed circuit board, HDI electronic materials, circuit boards